Relevance of T Lymphocytes Tumor Infiltrates CD8 and Foxp3 as Immune Prognostic Biomarker in Breast Cancer Treated by Neo Adjuvant Chemotherapy

NCT01513408 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

500

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

OTHER: immunohistochemical detection of lymphocytes T CD8+/Foxp3 ratio

Sponsor

Centre Georges Francois Leclerc